Researchers at Memorial Sloan Kettering Cancer Center (MSK) have developed some of the first robust laboratory models of a ...

The TCS New York City Marathon took a troubling turn for a woman running to raise money and awareness for cancer research.

For the first time, the New York Jobs CEO Council (Jobs Council) and the Partnership for New York City are bringing Career ...

Discover Biodesix's Q3 2025 earnings: 20% revenue growth, expanding primary care adoption, and improved margins.

In an adapted excerpt from his book, An Exercise in Uncertainty, Jonathan Gluck shares the impact his cancer journey had on ...

Novel approach designed to address dysregulated RNA splicing events that drive tumor growth and disease progression across ...

"Madison Avenue Men," a series of private retail events organized by the Madison Avenue BID, will support the Food Bank and ...

Kevin O’Leary — the investor known for starring in the television show “Shark Tank” — judged six teams of Harvard students on ...

Recently approved by the European Medicines Agency, RESTORE will evaluate iadademstat’s ability to raise fetal hemoglobin (HbF) in adult patients ...

SELLAS Life Sciences Group, Inc. (NASDAQ: SLS) ('SELLAS’’ or the 'Company”), a late-stage clinical biopharmaceutical company focused on the development of novel therapies for a broad range of cancer ...

Recently approved by the European Medicines Agency, RESTORE will evaluate iadademstat's ability to raise fetal hemoglobin (HbF) in adult patients with SCDIadademstat has demonstrated a favorable safet ...

Biodesix Inc (BDSX) reports a 20% revenue increase and improved margins, but faces challenges with net losses and rising ...